Literature DB >> 2541507

Clinical and radiologic analysis of 13 cases of primary neuroectodermal tumors of bone.

B Rousselin1, D Vanel, M J Terrier-Lacombe, B J Istria, M Spielman, J Masselot.   

Abstract

Radiographs and clinical charts were reviewed in a series of 13 cases of primary neuroectodermal bone tumors, involving 9 males and 4 females, aged from 3 to 32 years (average: 15 years). The average delay between the onset and diagnosis was 5 months. Fever and other systemic symptoms were present in 6 cases; in 4 cases a fracture was the mode of presentation. Seven patients had metastases (4 involving bone) at the time of presentation. Only one patient is still alive after 5 years. In the 10 patients who died as a direct result of the tumor, death occured on average 8 months following diagnosis if metastases were present initially, and 36 months after the diagnosis otherwise. Tumors predominantly involved the leg (7 cases), the pelvis (2 cases), and the humerus (2 cases), the involvement being both diaphyseal and metaphyseal. The radiologic appearance is that of an aggressive, poorly demarcated tumor, with cortical destruction, periosteal reaction and soft tissue invasion. Comparison with Ewing sarcoma shows little radiologic or clinical difference, except for a poorer prognosis in neuroectodermal bone tumors. Both bone tumors may have a similar neuroectodermal origin, with Ewing sarcoma representing the undifferentiated variety.

Entities:  

Mesh:

Year:  1989        PMID: 2541507     DOI: 10.1007/bf00350659

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  22 in total

1.  Malignant thoracopulmonary small-cell ("Askin") tumor.

Authors:  I J Fink; D W Kurtz; L Cazenave; M R Lieber; J S Miser; R Chandra; T J Triche
Journal:  AJR Am J Roentgenol       Date:  1985-09       Impact factor: 3.959

2.  Neuroectoderm-associated antigens on Ewing's sarcoma cell lines.

Authors:  M Lipinski; K Braham; I Philip; J Wiels; T Philip; C Goridis; G M Lenoir; T Tursz
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

3.  Chromosome study of Ewing's sarcoma (ES) cell lines. Consistency of a reciprocal translocation t(11;22)(q24;q12).

Authors:  C Turc-Carel; I Philip; M P Berger; T Philip; G M Lenoir
Journal:  Cancer Genet Cytogenet       Date:  1984-05

4.  Peripheral neuroectodermal tumors of the chest wall in childhood.

Authors:  F Gonzalez-Crussi; S L Wolfson; K Misugi; T Nakajima
Journal:  Cancer       Date:  1984-12-01       Impact factor: 6.860

5.  Determining growth rates of focal lesions of bone from radiographs.

Authors:  G S Lodwick; A J Wilson; C Farrell; P Virtama; F Dittrich
Journal:  Radiology       Date:  1980-03       Impact factor: 11.105

6.  Metastatic neuroblastoma in bone presenting the Ewing syndrome, with a discussion of "Ewing's sarcoma".

Authors:  R A Willis
Journal:  Am J Pathol       Date:  1940-05       Impact factor: 4.307

7.  Diagnosis of soft tissue sarcomas.

Authors:  M Enjoji; H Hashimoto
Journal:  Pathol Res Pract       Date:  1984-01       Impact factor: 3.250

8.  Malignant neuroepithelioma (peripheral neuroblastoma). A clinicopathologic study of 15 cases.

Authors:  H Hashimoto; M Enjoji; T Nakajima; H Kiryu; Y Daimaru
Journal:  Am J Surg Pathol       Date:  1983-06       Impact factor: 6.394

9.  A neuroendocrine tumor of the small intestine with a karyotype of 46,XY,t(11;22).

Authors:  N V Vigfusson; L J Allen; J H Phillips; T Alschibaja; W G Riches
Journal:  Cancer Genet Cytogenet       Date:  1986-07

10.  Peripheral neuroepithelioma in childhood.

Authors:  B L Voss; T J Pysher; G B Humphrey
Journal:  Cancer       Date:  1984-12-15       Impact factor: 6.860

View more
  2 in total

1.  Primitive neuroectodermal tumor in a child with tuberous sclerosis.

Authors:  B W Hindman; H K Gill; C W Zuppan
Journal:  Skeletal Radiol       Date:  1997-03       Impact factor: 2.199

2.  Simultaneous (synchronous) occurrence of Ewing sarcoma.

Authors:  G Beluffi; K Kozlowski; M Aricó
Journal:  Pediatr Radiol       Date:  1991
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.